Related Experiment Videos
Gender-related differences in takotsubo cardiomyopathy
Birke Schneider1, Anastasios Athanasiadis, Udo Sechtem
1Medizinische Klinik II, Sana Kliniken Lübeck, Kronsforder Allee 71 - 73, D-23562 Lübeck, Germany. b.schneider@sana-luebeck.de
Heart Failure Clinics
|April 9, 2013
Summary
Takotsubo cardiomyopathy (TTC) affects mostly elderly women, but men present similarly. However, men experience more physical stress triggers and severe outcomes like shock or cardiac arrest.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Internal Medicine
Background:
- Takotsubo cardiomyopathy (TTC) is a condition predominantly affecting elderly women.
- Men represent 10% of TTC cases, exhibiting a similar clinical profile to women.
- Existing research indicates no significant gender differences in age distribution, angina symptoms, or prehospital delay for TTC.
Purpose of the Study:
- To investigate gender-related differences in Takotsubo cardiomyopathy.
- To elucidate the pathogenetic background of TTC.
- To inform the development of preventive and therapeutic strategies for TTC.
Main Methods:
- Comparative analysis of clinical data between male and female TTC patients.
- Review of existing literature on gender disparities in TTC.
- Exploration of potential clinical and experimental differences.
Main Results:
- While clinical presentation is similar, men with TTC are more frequently triggered by physical stress.
- Men with TTC show a higher incidence of shock or cardiac arrest upon presentation.
- Despite similarities in symptoms and delay, significant gender discrepancies in TTC prevalence warrant further investigation.
Conclusions:
- Gender-related differences in TTC, particularly concerning triggers and acute outcomes, require thorough investigation.
- Understanding these differences is crucial for explaining prevalence disparities and advancing TTC management.
- Further clinical and experimental research is essential to address the life-threatening nature of TTC.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...